These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24448890)

  • 21. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular reprogramming--lowering gravity on Waddington's epigenetic landscape.
    Takahashi K
    J Cell Sci; 2012 Jun; 125(Pt 11):2553-60. PubMed ID: 22736045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reprogramming somatic cells to a kidney fate.
    Takasato M; Vanslambrouck JM; Little MH
    Semin Nephrol; 2014 Jul; 34(4):462-80. PubMed ID: 25217274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removing reprogramming roadblocks: Mbd3 depletion allows deterministic iPSC generation.
    Brumbaugh J; Hochedlinger K
    Cell Stem Cell; 2013 Oct; 13(4):379-81. PubMed ID: 24094318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling and quantification of pluripotency reprogramming reveal that WNT pathways and cell morphology have to be reprogramed extensively.
    Hu K; Ianov L; Crossman D
    Heliyon; 2020 May; 6(5):e04035. PubMed ID: 32490244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic stem cell states: naive to primed pluripotency in rodents and humans.
    Weinberger L; Ayyash M; Novershtern N; Hanna JH
    Nat Rev Mol Cell Biol; 2016 Mar; 17(3):155-69. PubMed ID: 26860365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming cell fates: reconciling rarity with robustness.
    Huang S
    Bioessays; 2009 May; 31(5):546-60. PubMed ID: 19319911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stochastic model of epigenetic dynamics in somatic cell reprogramming.
    Flöttmann M; Scharp T; Klipp E
    Front Physiol; 2012; 3():216. PubMed ID: 22754535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Emerging View of Aging as a Reversible Epigenetic Process.
    López-León M; Goya RG
    Gerontology; 2017; 63(5):426-431. PubMed ID: 28538216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the role of Sirtuins in cell reprogramming.
    Shin J; Kim J; Park H; Kim J
    BMB Rep; 2018 Oct; 51(10):500-507. PubMed ID: 30037368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring oocyte-based human pluripotency acquisition using synchrotron-based FTIR microspectroscopy reveals specific biomolecular trajectories.
    Dučić T; Sanchez-Mata A; Castillo-Sanchez J; Algarra M; Gonzalez-Munoz E
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Sep; 297():122713. PubMed ID: 37084681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct reprogramming of adult cells: avoiding the pluripotent state.
    Kelaini S; Cochrane A; Margariti A
    Stem Cells Cloning; 2014; 7():19-29. PubMed ID: 24627642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic distribution decomposition for single-cell snapshot time series identifies subpopulations and trajectories during iPSC reprogramming.
    Taylor-King JP; Riseth AN; Macnair W; Claassen M
    PLoS Comput Biol; 2020 Jan; 16(1):e1007491. PubMed ID: 31923173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phases of reprogramming.
    David L; Polo JM
    Stem Cell Res; 2014 May; 12(3):754-61. PubMed ID: 24735951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric Cell Division of Fibroblasts is An Early Deterministic Step to Generate Elite Cells during Cell Reprogramming.
    Song Y; Soto J; Wang P; An Q; Zhang X; Hong S; Lee LP; Fan G; Yang L; Li S
    Adv Sci (Weinh); 2021 Apr; 8(7):2003516. PubMed ID: 33854891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative parallel multi-omics analysis during the induction of pluripotent and trophectoderm states.
    Jaber M; Radwan A; Loyfer N; Abdeen M; Sebban S; Khatib A; Yassen H; Kolb T; Zapatka M; Makedonski K; Ernst A; Kaplan T; Buganim Y
    Nat Commun; 2022 Jun; 13(1):3475. PubMed ID: 35715410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA-Based Strategies for Cell Reprogramming toward Pluripotency.
    Bailly A; Milhavet O; Lemaitre JM
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disentangling a complex response in cell reprogramming and probing the Waddington landscape by automatic construction of Petri nets.
    Rätzel V; Werthmann B; Haas M; Strube J; Marwan W
    Biosystems; 2020 Mar; 189():104092. PubMed ID: 31917281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular reprogramming for understanding and treating human disease.
    Kanherkar RR; Bhatia-Dey N; Makarev E; Csoka AB
    Front Cell Dev Biol; 2014; 2():67. PubMed ID: 25429365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of different choices and treatments with donor cells on reprogramming].
    Yao YX; Li XC; Zhang Y; Qiao LM; Guan WJ; Ma YH
    Yi Chuan; 2008 Nov; 30(11):1392-6. PubMed ID: 19073545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.